ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Interleukin Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-11L3851
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Interleukin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Recombinant Human Interleukin Market Insights, Forecast to 2030

Code: QYRE-Auto-11L3851
Report
December 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qilu Pharmaceutical
Hangzhou Jiuyuan
Merck and Co.
Novartis Pharma
Abnova
Advanced Biotechnologies Inc
Cayman Chemical
Cell Signaling Technology
Thermo Fisher

Recombinant Human Interleukin Market

Interleukins (ILs) are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes). ILs can be divided into four major groups based on distinguishing structural features. However, their amino acid sequence similarity is rather weak (typically 15–25% identity). The human genome encodes more than 50 interleukins and related proteins.
The global Recombinant Human Interleukin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Recombinant Human Interleukin include Qilu Pharmaceutical, Hangzhou Jiuyuan, Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology and Thermo Fisher, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Recombinant Human Interleukin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Interleukin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Interleukin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Interleukin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Interleukin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Interleukin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Recombinant Human Interleukin Market Report

Report Metric Details
Report Name Recombinant Human Interleukin Market
Segment by Type
  • IL-1
  • IL-2
  • IL-10
  • Others
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology, Thermo Fisher
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Recombinant Human Interleukin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Recombinant Human Interleukin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Interleukin sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Human Interleukin Market report?

Ans: The main players in the Recombinant Human Interleukin Market are Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology, Thermo Fisher

What are the Application segmentation covered in the Recombinant Human Interleukin Market report?

Ans: The Applications covered in the Recombinant Human Interleukin Market report are Medication, Scientific Research

What are the Type segmentation covered in the Recombinant Human Interleukin Market report?

Ans: The Types covered in the Recombinant Human Interleukin Market report are IL-1, IL-2, IL-10, Others

Recommended Reports

Recombinant Human Proteins

Interleukin & Cytokine

Recombinant Protein Therapeutics

1 Study Coverage
1.1 Recombinant Human Interleukin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Interleukin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IL-1
1.2.3 IL-2
1.2.4 IL-10
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Interleukin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medication
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Interleukin Revenue by Region
2.2.1 Global Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Interleukin Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Interleukin Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Interleukin Sales by Region
2.4.1 Global Recombinant Human Interleukin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Interleukin Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Interleukin Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Interleukin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Interleukin Sales by Manufacturers
3.1.1 Global Recombinant Human Interleukin Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Interleukin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Interleukin in 2023
3.2 Global Recombinant Human Interleukin Revenue by Manufacturers
3.2.1 Global Recombinant Human Interleukin Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Interleukin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Interleukin Revenue in 2023
3.3 Global Key Players of Recombinant Human Interleukin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Interleukin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Interleukin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Interleukin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Interleukin Sales by Type
4.1.1 Global Recombinant Human Interleukin Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Interleukin Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Interleukin Revenue by Type
4.2.1 Global Recombinant Human Interleukin Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Interleukin Price by Type
4.3.1 Global Recombinant Human Interleukin Price by Type (2019-2024)
4.3.2 Global Recombinant Human Interleukin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Interleukin Sales by Application
5.1.1 Global Recombinant Human Interleukin Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Interleukin Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Interleukin Revenue by Application
5.2.1 Global Recombinant Human Interleukin Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Interleukin Price by Application
5.3.1 Global Recombinant Human Interleukin Price by Application (2019-2024)
5.3.2 Global Recombinant Human Interleukin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Interleukin Market Size by Type
6.1.1 US & Canada Recombinant Human Interleukin Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Interleukin Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Interleukin Market Size by Application
6.2.1 US & Canada Recombinant Human Interleukin Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Interleukin Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Interleukin Market Size by Country
6.3.1 US & Canada Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Interleukin Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Interleukin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Interleukin Market Size by Type
7.1.1 Europe Recombinant Human Interleukin Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Interleukin Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Interleukin Market Size by Application
7.2.1 Europe Recombinant Human Interleukin Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Interleukin Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Interleukin Market Size by Country
7.3.1 Europe Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Interleukin Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Interleukin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Interleukin Market Size
8.1.1 China Recombinant Human Interleukin Sales (2019-2030)
8.1.2 China Recombinant Human Interleukin Revenue (2019-2030)
8.2 China Recombinant Human Interleukin Market Size by Application
8.2.1 China Recombinant Human Interleukin Sales by Application (2019-2030)
8.2.2 China Recombinant Human Interleukin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Interleukin Market Size by Type
9.1.1 Asia Recombinant Human Interleukin Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Interleukin Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Interleukin Market Size by Application
9.2.1 Asia Recombinant Human Interleukin Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Interleukin Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Interleukin Sales by Region
9.3.1 Asia Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Interleukin Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Interleukin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Overview
11.1.3 Qilu Pharmaceutical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Qilu Pharmaceutical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qilu Pharmaceutical Recent Developments
11.2 Hangzhou Jiuyuan
11.2.1 Hangzhou Jiuyuan Company Information
11.2.2 Hangzhou Jiuyuan Overview
11.2.3 Hangzhou Jiuyuan Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Hangzhou Jiuyuan Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hangzhou Jiuyuan Recent Developments
11.3 Merck and Co
11.3.1 Merck and Co Company Information
11.3.2 Merck and Co Overview
11.3.3 Merck and Co Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck and Co Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck and Co Recent Developments
11.4 Novartis Pharma
11.4.1 Novartis Pharma Company Information
11.4.2 Novartis Pharma Overview
11.4.3 Novartis Pharma Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis Pharma Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Pharma Recent Developments
11.5 Abnova
11.5.1 Abnova Company Information
11.5.2 Abnova Overview
11.5.3 Abnova Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Abnova Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abnova Recent Developments
11.6 Advanced Biotechnologies Inc
11.6.1 Advanced Biotechnologies Inc Company Information
11.6.2 Advanced Biotechnologies Inc Overview
11.6.3 Advanced Biotechnologies Inc Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Advanced Biotechnologies Inc Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Advanced Biotechnologies Inc Recent Developments
11.7 Cayman Chemical
11.7.1 Cayman Chemical Company Information
11.7.2 Cayman Chemical Overview
11.7.3 Cayman Chemical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Cayman Chemical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cayman Chemical Recent Developments
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Information
11.8.2 Cell Signaling Technology Overview
11.8.3 Cell Signaling Technology Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cell Signaling Technology Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cell Signaling Technology Recent Developments
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Information
11.9.2 Thermo Fisher Overview
11.9.3 Thermo Fisher Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Thermo Fisher Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Thermo Fisher Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Interleukin Industry Chain Analysis
12.2 Recombinant Human Interleukin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Interleukin Production Mode & Process
12.4 Recombinant Human Interleukin Sales and Marketing
12.4.1 Recombinant Human Interleukin Sales Channels
12.4.2 Recombinant Human Interleukin Distributors
12.5 Recombinant Human Interleukin Customers
13 Market Dynamics
13.1 Recombinant Human Interleukin Industry Trends
13.2 Recombinant Human Interleukin Market Drivers
13.3 Recombinant Human Interleukin Market Challenges
13.4 Recombinant Human Interleukin Market Restraints
14 Key Findings in The Global Recombinant Human Interleukin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Qilu Pharmaceutical
Hangzhou Jiuyuan
Merck and Co.
Novartis Pharma
Abnova
Advanced Biotechnologies Inc
Cayman Chemical
Cell Signaling Technology
Thermo Fisher
List of Tables
    Table 1. Global Recombinant Human Interleukin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of IL-1
    Table 3. Major Manufacturers of IL-2
    Table 4. Major Manufacturers of IL-10
    Table 5. Major Manufacturers of Others
    Table 6. Global Recombinant Human Interleukin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Recombinant Human Interleukin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Recombinant Human Interleukin Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Recombinant Human Interleukin Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2024)
    Table 11. Global Recombinant Human Interleukin Revenue Market Share by Region (2025-2030)
    Table 12. Global Recombinant Human Interleukin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Recombinant Human Interleukin Sales by Region (2019-2024) & (KG)
    Table 14. Global Recombinant Human Interleukin Sales by Region (2025-2030) & (KG)
    Table 15. Global Recombinant Human Interleukin Sales Market Share by Region (2019-2024)
    Table 16. Global Recombinant Human Interleukin Sales Market Share by Region (2025-2030)
    Table 17. Global Recombinant Human Interleukin Sales by Manufacturers (2019-2024) & (KG)
    Table 18. Global Recombinant Human Interleukin Sales Share by Manufacturers (2019-2024)
    Table 19. Global Recombinant Human Interleukin Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Recombinant Human Interleukin Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Recombinant Human Interleukin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Recombinant Human Interleukin Price by Manufacturers 2019-2024 (USD/g)
    Table 23. Global Recombinant Human Interleukin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Recombinant Human Interleukin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Interleukin as of 2023)
    Table 25. Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Recombinant Human Interleukin, Product Offered and Application
    Table 27. Global Key Manufacturers of Recombinant Human Interleukin, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 30. Global Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 31. Global Recombinant Human Interleukin Sales Share by Type (2019-2024)
    Table 32. Global Recombinant Human Interleukin Sales Share by Type (2025-2030)
    Table 33. Global Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Recombinant Human Interleukin Revenue Share by Type (2019-2024)
    Table 36. Global Recombinant Human Interleukin Revenue Share by Type (2025-2030)
    Table 37. Recombinant Human Interleukin Price by Type (2019-2024) & (USD/g)
    Table 38. Global Recombinant Human Interleukin Price Forecast by Type (2025-2030) & (USD/g)
    Table 39. Global Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 40. Global Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 41. Global Recombinant Human Interleukin Sales Share by Application (2019-2024)
    Table 42. Global Recombinant Human Interleukin Sales Share by Application (2025-2030)
    Table 43. Global Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Recombinant Human Interleukin Revenue Share by Application (2019-2024)
    Table 46. Global Recombinant Human Interleukin Revenue Share by Application (2025-2030)
    Table 47. Recombinant Human Interleukin Price by Application (2019-2024) & (USD/g)
    Table 48. Global Recombinant Human Interleukin Price Forecast by Application (2025-2030) & (USD/g)
    Table 49. US & Canada Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 50. US & Canada Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 51. US & Canada Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 54. US & Canada Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 55. US & Canada Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Recombinant Human Interleukin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
    Table 61. US & Canada Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
    Table 62. Europe Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 63. Europe Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 64. Europe Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 67. Europe Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 68. Europe Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Recombinant Human Interleukin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
    Table 74. Europe Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
    Table 75. China Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 76. China Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 77. China Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 80. China Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 81. China Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 84. Asia Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 85. Asia Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 88. Asia Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 89. Asia Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Recombinant Human Interleukin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Recombinant Human Interleukin Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Recombinant Human Interleukin Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Recombinant Human Interleukin Sales by Region (2019-2024) & (KG)
    Table 95. Asia Recombinant Human Interleukin Sales by Region (2025-2030) & (KG)
    Table 96. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Type (2019-2024) & (KG)
    Table 97. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Type (2025-2030) & (KG)
    Table 98. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Application (2019-2024) & (KG)
    Table 101. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Application (2025-2030) & (KG)
    Table 102. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
    Table 108. Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
    Table 109. Qilu Pharmaceutical Company Information
    Table 110. Qilu Pharmaceutical Description and Major Businesses
    Table 111. Qilu Pharmaceutical Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 112. Qilu Pharmaceutical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Qilu Pharmaceutical Recent Developments
    Table 114. Hangzhou Jiuyuan Company Information
    Table 115. Hangzhou Jiuyuan Description and Major Businesses
    Table 116. Hangzhou Jiuyuan Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 117. Hangzhou Jiuyuan Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Hangzhou Jiuyuan Recent Developments
    Table 119. Merck and Co Company Information
    Table 120. Merck and Co Description and Major Businesses
    Table 121. Merck and Co Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 122. Merck and Co Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Merck and Co Recent Developments
    Table 124. Novartis Pharma Company Information
    Table 125. Novartis Pharma Description and Major Businesses
    Table 126. Novartis Pharma Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 127. Novartis Pharma Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Novartis Pharma Recent Developments
    Table 129. Abnova Company Information
    Table 130. Abnova Description and Major Businesses
    Table 131. Abnova Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 132. Abnova Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Abnova Recent Developments
    Table 134. Advanced Biotechnologies Inc Company Information
    Table 135. Advanced Biotechnologies Inc Description and Major Businesses
    Table 136. Advanced Biotechnologies Inc Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 137. Advanced Biotechnologies Inc Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Advanced Biotechnologies Inc Recent Developments
    Table 139. Cayman Chemical Company Information
    Table 140. Cayman Chemical Description and Major Businesses
    Table 141. Cayman Chemical Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 142. Cayman Chemical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Cayman Chemical Recent Developments
    Table 144. Cell Signaling Technology Company Information
    Table 145. Cell Signaling Technology Description and Major Businesses
    Table 146. Cell Signaling Technology Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 147. Cell Signaling Technology Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Cell Signaling Technology Recent Developments
    Table 149. Thermo Fisher Company Information
    Table 150. Thermo Fisher Description and Major Businesses
    Table 151. Thermo Fisher Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 152. Thermo Fisher Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Thermo Fisher Recent Developments
    Table 154. Key Raw Materials Lists
    Table 155. Raw Materials Key Suppliers Lists
    Table 156. Recombinant Human Interleukin Distributors List
    Table 157. Recombinant Human Interleukin Customers List
    Table 158. Recombinant Human Interleukin Market Trends
    Table 159. Recombinant Human Interleukin Market Drivers
    Table 160. Recombinant Human Interleukin Market Challenges
    Table 161. Recombinant Human Interleukin Market Restraints
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Human Interleukin Product Picture
    Figure 2. Global Recombinant Human Interleukin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Recombinant Human Interleukin Market Share by Type in 2023 & 2030
    Figure 4. IL-1 Product Picture
    Figure 5. IL-2 Product Picture
    Figure 6. IL-10 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Recombinant Human Interleukin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Recombinant Human Interleukin Market Share by Application in 2023 & 2030
    Figure 10. Medication
    Figure 11. Scientific Research
    Figure 12. Recombinant Human Interleukin Report Years Considered
    Figure 13. Global Recombinant Human Interleukin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Recombinant Human Interleukin Revenue 2019-2030 (US$ Million)
    Figure 15. Global Recombinant Human Interleukin Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2030)
    Figure 17. Global Recombinant Human Interleukin Sales 2019-2030 ((KG)
    Figure 18. Global Recombinant Human Interleukin Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Recombinant Human Interleukin Sales YoY (2019-2030) & (KG)
    Figure 20. US & Canada Recombinant Human Interleukin Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Recombinant Human Interleukin Sales YoY (2019-2030) & (KG)
    Figure 22. Europe Recombinant Human Interleukin Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Recombinant Human Interleukin Sales YoY (2019-2030) & (KG)
    Figure 24. China Recombinant Human Interleukin Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Recombinant Human Interleukin Sales YoY (2019-2030) & (KG)
    Figure 26. Asia (excluding China) Recombinant Human Interleukin Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Recombinant Human Interleukin Sales YoY (2019-2030) & (KG)
    Figure 28. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Recombinant Human Interleukin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Recombinant Human Interleukin in the World: Market Share by Recombinant Human Interleukin Revenue in 2023
    Figure 31. Global Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 33. Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 34. Global Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 35. Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Recombinant Human Interleukin Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Recombinant Human Interleukin Sales Share by Country (2019-2030)
    Figure 42. U.S. Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 45. Europe Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 47. Europe Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Recombinant Human Interleukin Revenue Share by Country (2019-2030)
    Figure 49. Europe Recombinant Human Interleukin Sales Share by Country (2019-2030)
    Figure 50. Germany Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 51. France Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 55. China Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 56. China Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 57. China Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 58. China Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 60. Asia Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 62. Asia Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Recombinant Human Interleukin Revenue Share by Region (2019-2030)
    Figure 64. Asia Recombinant Human Interleukin Sales Share by Region (2019-2030)
    Figure 65. Japan Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 69. India Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Recombinant Human Interleukin Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Recombinant Human Interleukin Sales Share by Country (2019-2030)
    Figure 76. Brazil Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Recombinant Human Interleukin Revenue (2019-2030) & (US$ Million)
    Figure 81. Recombinant Human Interleukin Value Chain
    Figure 82. Recombinant Human Interleukin Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Interleukin Market Research Report 2025
Global GMP Interleukin Market Insights Forecast to 2030
Proleukin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytokines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Recombinant Cytokines Drug Market Insights Forecast to 2030
Global Cytokines as Cell Culture Supplements Market Research Report 2024
Recombinant Interferon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Interleukin 2 for Injection Market Research Report 2025
Global IL 4Rα Targeting Drugs Market Research Report 2024
Interferon Alpha 2a Biosimilar Market
Global Human Interleukin 2 IL 2 Market Research Report 2024
Global Interleukin 11 IL 11 Market Research Report 2024
Global α Interferon Market Research Report 2024
Global Long lasting Interferon Market Insights Forecast to 2030
Aldesleukin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IL 4Rα Monoclonal Antibody Drug Market Research Report 2024
Interferon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bovine Interleukin 2 IL2 ELISA Kit Market Research Report 2024
Global Anti Inflammatory Cytokine Market Research Report 2025
Global Culture Media Cytokines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions